Brooker LA - Search Results

1

Chan AK, Deveber G, Monagle P, Brooker LA, Massicotte PM. Chan AK, et al. Among authors: brooker la. J Thromb Haemost. 2003 Jul;1(7):1443-55. doi: 10.1046/j.1538-7836.2003.00308.x. J Thromb Haemost. 2003. PMID: 12871279 Free article. Review.

2

Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.

Chan AK, Leaker M, Burrows FA, Williams WG, Gruenwald CE, Whyte L, Adams M, Brooker LA, Adams H, Mitchell L, Andrew M. Chan AK, et al. Among authors: brooker la. Thromb Haemost. 1997 Feb;77(2):270-7. Thromb Haemost. 1997. PMID: 9157580

3

Arterial thromboembolic complications in paediatric patients.

Andrew M, David M, deVeber G, Brooker LA. Andrew M, et al. Among authors: brooker la. Thromb Haemost. 1997 Jul;78(1):715-25. Thromb Haemost. 1997. PMID: 9198245 Review. No abstract available.

4

The influence of developmental haemostasis on the laboratory diagnosis and management of haemostatic disorders during infancy and childhood.

Male C, Johnston M, Sparling C, Brooker L, Andrew M, Massicotte P. Male C, et al. Clin Lab Med. 1999 Mar;19(1):39-69. Clin Lab Med. 1999. PMID: 10403074 Review.

5

Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study.

Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Massicotte P, et al. Among authors: brooker la. J Pediatr. 1996 Mar;128(3):313-8. doi: 10.1016/s0022-3476(96)70273-1. J Pediatr. 1996. PMID: 8774496

6

The prevention and treatment of thromboembolic disease in children: a need for Thrombophilia Programs.

Andrew M, Michelson AD, Bovill T, Leaker M, Massicotte P, Marzinotto V, Brooker LA. Andrew M, et al. Among authors: brooker la. J Pediatr Hematol Oncol. 1997 Jan-Feb;19(1):7-22. doi: 10.1097/00043426-199701000-00002. J Pediatr Hematol Oncol. 1997. PMID: 9065714 Review. No abstract available.

7

Antithrombotic properties of heparin in a neonatal piglet model of thrombin-induced thrombosis.

Schmidt B, Buchanan MR, Ofosu F, Brooker L, Hirsh J, Andrew M. Schmidt B, et al. Thromb Haemost. 1988 Oct 31;60(2):289-92. Thromb Haemost. 1988. PMID: 3217922

8

Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.

Sharathkumar A, Lillicrap D, Blanchette VS, Kern M, Leggo J, Stain AM, Brooker L, Carcao MD. Sharathkumar A, et al. J Thromb Haemost. 2003 Jun;1(6):1228-36. doi: 10.1046/j.1538-7836.2003.00230.x. J Thromb Haemost. 2003. PMID: 12871324 Free article. Review.

9

Oral anticoagulation therapy in pediatric patients: a prospective study.

Andrew M, Marzinotto V, Brooker LA, Adams M, Ginsberg J, Freedom R, Williams W. Andrew M, et al. Among authors: brooker la. Thromb Haemost. 1994 Mar;71(3):265-9. Thromb Haemost. 1994. PMID: 8029786

10

Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.

Andrew M, Brooker L, Leaker M, Paes B, Weitz J. Andrew M, et al. Thromb Haemost. 1992 Sep 7;68(3):325-30. Thromb Haemost. 1992. PMID: 1440499

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters